Literature DB >> 11461080

Expression of the normal epithelial cell-specific 1 (NES1; KLK10) candidate tumour suppressor gene in normal and malignant testicular tissue.

L Y Luo1, E R Rajpert-De Meyts, K Jung, E P Diamandis.   

Abstract

The normal epithelial cell-specific 1 (NES1) gene (official name kallikrein gene 10; KLK10) is a new member of the expanding human kallikrein gene family and encodes for a secreted serine protease. Experimental evidence suggests that NES1 controls normal cell growth and may function as a tumour suppressor. NES1 is down-regulated during breast cancer progression. The NES1 gene is highly expressed in testicular as well as in other tissues. In this study, we investigated the expression level of the NES1 gene in cancerous and normal testicular tissues with reverse transcriptase-polymerase chain reaction (RT-PCR) and immunohistochemistry. In all 14 primary testicular germ-cell tumours examined, the NES1 gene expression was markedly reduced compared to adjacent (paired) normal tissues. We further examined 6 randomly selected primary germ-cell tumours and 8 normal tissues (obtained from different individuals). We confirmed the differential expression of the NES1 gene in germ-cell tumours (GCT) and pre-malignant carcinoma in situ (CIS). Our findings suggest that NES1 may act as a tumour suppressor and may play a role in the pathogenesis and progression of this malignancy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11461080      PMCID: PMC2364047          DOI: 10.1054/bjoc.2001.1870

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

1.  Cell cycle regulators in testicular cancer: loss of p18INK4C marks progression from carcinoma in situ to invasive germ cell tumours.

Authors:  J Bartkova; M Thullberg; E Rajpert-De Meyts; N E Skakkebaek; J Bartek
Journal:  Int J Cancer       Date:  2000-02-01       Impact factor: 7.396

Review 2.  New tumor markers of testis cancer.

Authors:  R C Dean; J W Moul
Journal:  Urol Clin North Am       Date:  1998-08       Impact factor: 2.241

3.  Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.

Authors:  T A Stamey; N Yang; A R Hay; J E McNeal; F S Freiha; E Redwine
Journal:  N Engl J Med       Date:  1987-10-08       Impact factor: 91.245

4.  The combination of human glandular kallikrein and free prostate-specific antigen (PSA) enhances discrimination between prostate cancer and benign prostatic hyperplasia in patients with moderately increased total PSA.

Authors:  A Magklara; A Scorilas; W J Catalona; E P Diamandis
Journal:  Clin Chem       Date:  1999-11       Impact factor: 8.327

5.  Possible carcinoma-in-situ of the testis.

Authors:  N E Skakkebaek
Journal:  Lancet       Date:  1972-09-09       Impact factor: 79.321

Review 6.  Pathogenesis of testicular germ cell tumours.

Authors:  L H Looijenga; J W Oosterhuis
Journal:  Rev Reprod       Date:  1999-05

7.  Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma.

Authors:  N E Skakkebaek; J G Berthelsen; A Giwercman; J Müller
Journal:  Int J Androl       Date:  1987-02

Review 8.  The new human kallikrein gene family: implications in carcinogenesis.

Authors:  E P Diamandis; G M Yousef; L Y Luo; A Magklara; C V Obiezu
Journal:  Trends Endocrinol Metab       Date:  2000-03       Impact factor: 12.015

9.  Positive selection of candidate tumor-suppressor genes by subtractive hybridization.

Authors:  S W Lee; C Tomasetto; R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

10.  Structural characterization and mapping of the normal epithelial cell-specific 1 gene.

Authors:  L Luo; J A Herbrick; S W Scherer; B Beatty; J Squire; E P Diamandis
Journal:  Biochem Biophys Res Commun       Date:  1998-06-29       Impact factor: 3.575

View more
  16 in total

Review 1.  Kallikreins - The melting pot of activity and function.

Authors:  Magdalena Kalinska; Ulf Meyer-Hoffert; Tomasz Kantyka; Jan Potempa
Journal:  Biochimie       Date:  2015-09-25       Impact factor: 4.079

2.  MiR-194-3p modulates the progression of colorectal cancer by targeting KLK10.

Authors:  Tao Liu; Yuejun Fang
Journal:  Histol Histopathol       Date:  2021-12-22       Impact factor: 2.303

3.  Rare Variants in Novel Candidate Genes Associated With Nonsyndromic Patent Ductus Arteriosus Identified With Whole-Exome Sequencing.

Authors:  Ying Gao; Dan Wu; Bo Chen; Yinghui Chen; Qi Zhang; Pengjun Zhao
Journal:  Front Genet       Date:  2022-06-06       Impact factor: 4.772

4.  The canine kallikrein-related peptidases 9 and 10: structural characterization and expression in mammary cancer.

Authors:  Katerina Angelopoulou; George S Karagiannis
Journal:  Mamm Genome       Date:  2009-12-02       Impact factor: 2.957

5.  Suppression of gastric cancer growth by baculovirus vector-mediated transfer of normal epithelial cell specific-1 gene.

Authors:  Wei Huang; Xiang-Long Tian; Yun-Lin Wu; Jie Zhong; Li-Fen Yu; Sheng-Ping Hu; Biao Li
Journal:  World J Gastroenterol       Date:  2008-10-14       Impact factor: 5.742

6.  Evaluation and prognostic significance of human tissue kallikrein-related peptidase 10 (KLK10) in colorectal cancer.

Authors:  Constantina Petraki; Youssef M Youssef; William Dubinski; Zsuzsanna Lichner; Andreas Scorilas; Maria D Pasic; Vassilios Komborozos; Bishoy Khalil; Catherine Streutker; Eleftherios P Diamandis; George M Yousef
Journal:  Tumour Biol       Date:  2012-03-22

Review 7.  Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs).

Authors:  Peter Goettig; Viktor Magdolen; Hans Brandstetter
Journal:  Biochimie       Date:  2010-07-06       Impact factor: 4.079

8.  Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis.

Authors:  G M Yousef; C A Borgoño; A Scorilas; R Ponzone; N Biglia; L Iskander; M-E Polymeris; R Roagna; P Sismondi; E P Diamandis
Journal:  Br J Cancer       Date:  2002-11-18       Impact factor: 7.640

9.  Hypermethylation of the 5' CpG island of the gene encoding the serine protease Testisin promotes its loss in testicular tumorigenesis.

Authors:  K J Manton; M L Douglas; S Netzel-Arnett; D R Fitzpatrick; D L Nicol; A W Boyd; J A Clements; T M Antalis
Journal:  Br J Cancer       Date:  2005-02-28       Impact factor: 7.640

10.  The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer.

Authors:  M Talieri; L Li; Y Zheng; D K Alexopoulou; A Soosaipillai; A Scorilas; D Xynopoulos; E P Diamandis
Journal:  Br J Cancer       Date:  2009-04-14       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.